**Please note, in the archived version of the webinar there was a slight technical issue and webinar begins without Dr. Trooskin's introduction of her talk. That information can be found within the event description.**

The purpose of this webinar is to enable participants to increase their knowledge regarding Hepatitis C Treatment in People with Substance Use Disorder.

Upon completion, participants will be able to: 

1. Describe the common barriers associated with hepatitis C treatment in People with Substance Use Disorder

2. Discuss the application of harm reduction principles to increase success in treating HCV infection in people who have substance use disorder

Speaker

Stacey Trooskin, MD, PhD, MPH
Director of Viral Hepatitis Programs,
Philadelphia FIGHT Community Health Centers
Clinical Assistant Professor of Medicine,
Perelman School of Medicine,
University of Pennsylvania

Disclosure(s)

Planners have no conflicts of interest relative to this educational activity.

Speaker disclosures - Dr. Trooskin has a Gilead Sciences grant and is on a Gilead Sciences Advisory board.